Inorganic Chemistry
Article
Ar−C, P{C6H5}3), 129.11 (d, JC−P = 10 Hz, Ar−C, P{C6H5}3), 128.83
(d, JC−P = 11 Hz, Ar−C, P{C6H5}3), 63.14 (s, CH2CH2O), 37.18
C84H100B2Cl2F30NiP4: C, 51.61; H, 5.16; Found: C, 50.76;18 H,
5.40. UV−vis: λmax (ε)/nm 382 (6096).
1
1
1
7. Pink powder. Yield 119 mg (75%). H NMR (CD2Cl2): 7.76
(d, JC−P = 27.5 Hz, P{C(CH3)3}2), 34.08 (d, JC−P = 16 Hz,
PCH2CH2), 30.01 (br d, P{C(CH3)3}2), 23.23 (s, CH2CH2O), 21.16
(s, 2H, NCHN), 6.98 (s, 8H, m-MesAr-H), 4.25 (s, 8H, NCH2CH2N),
2.44−1.29 (br m, 4H, P{C6H11}2), 2.29 (s, 12H, Mes-p-CH3), 2.23
(s, 24H, Mes-o-CH3). 11B NMR (CD2Cl2): −0.76 (br). 13C{1H} NMR
(CD2Cl2) partial: 158.90 (s, NCHN), 141.65 (s, ipso-MesAr−C-N),
135.22 (s, o-MesAr−C), 130.42 (s, m-MesAr−C), 129.93 (s, p-
MesAr−C), 51.70 (s, NCH2CH2N), 32.33 (br s, P{C6H11}2), 29.75
(br s, P{C6H11}2), 28.94 (br s, P{C6H11}2), 27.51 (br s, P{C6H11}2),
21.09 (s, Mes-p-CH3), 17.59 (s, Mes-o-CH3). 19F NMR (CD2Cl2):
−134.75 (br m, 8F, C6F4), −135.52 (br m, 8F, o-C6F5), −162.35
3
(s, PCH2CH2). 19F NMR (CD2Cl2): −133.80 (d, JF−F = 25 Hz, 6F,
3
3
o-C6F5), −163.96 (t, JF−F = 20 Hz, 3F p-C6F5), −167.43 (t, JF−F
=
=
19 Hz, 6F, m-C6F5). 31P{1H} NMR (CD2Cl2): 56.52 (dd, JP−Pt
1
3
1
2729 Hz, JP−P = 314, 17 Hz, PtBu2), 21.58 (dd, JP−Pt = 2247 Hz,
3JP−P = 20, 17 Hz, trans HPtPPh3), 18.38 (dd, 1JP−Pt = 2569 Hz, 3JP−P
=
314, 20 Hz, cis HPtPPh3). Anal. Calcd for C66H57BF15OP3Pt: C, 55.13;
H, 4.02; Found: C, 55.19; H, 4.32.
Synthesis of [BaseH][Cy2PC6F4BF(C6F5)2] (Base = tBu3P 4,
SIMes 5). These compounds were prepared in a similar fashion and
thus only one preparation is detailed. A clear, colorless solution of
t-Bu3P (0.057 g, 0.282 mmol) in toluene (4 mL) was added to a white
slurry of Cy2PHC6F4BF(C6F5)2 (0.200 g, 0.282 mmol) in toluene
(4 mL). The resulting reaction mixture was stirred at room
temperature overnight. All volatiles were removed via vacuum from
the clear, colorless solution. The residue was washed with 4 × 5 mL of
pentane and dried via vacuum.
3
(t, JF−F = 20 Hz, 4F, p-C6F5), −166.82 (br m, 8F, m-C6F5), −191.01
(br s, 2F, B-F).31P{1H} NMR (CD2Cl2): 10.60 (br s, PCy2). Anal.
Calcd for C102H98B2Cl2F30N4NiP2: C, 56.64; H, 4.57; N, 2.59; Found:
C, 55.94;18 H, 4.78; N, 2.47. UV−vis: λmax (ε)/nm 382 (8525).
Synthesis of [tBu3PH]2[trans-Cl2Pd(Cy2PC6F4BF(C6F5)2)2] 8,
[SIMesH]2[trans-PdCl2(Cy2PC6F4BF(C6F5)2)2] 9, and [SIMesH]2-
[trans-PdCl2(tBu2P(CH2)4OB(C6F5)3)2] 15. These compounds were
prepared in a similar fashion and thus only one preparation is detailed.
A solution of PdCl2(PhCN)2 (0.014 g, 0.037 mmol) in dichloro-
methane (3 mL) was added to a solution of 5 (0.0668 g, 0.073 mmol)
in dichloromethane (3 mL). The reaction mixture was stirred at room
temperature overnight to give a clear, bright yellow solution. The
reaction mixture was concentrated to 1 mL under vacuum. Ten
milliliters of pentane were added to precipitate a yellow solid. The
solvent was decanted, and the solid washed with a further 5 mL of
pentane and dried under vacuum. The final product was a pale yellow
powder.
4. white powder. Yield 240 mg (93%). 1H NMR (C6D6): 6.09
1
(d, JH−P = 472 Hz, 1H, H-P{C(CH3)3}3), 2.39−1.08 (br m, 22 H,
3
P{C6H11}2), 0.79 (d, JH−P = 15 Hz, 18H, H−P{C(CH3)3}3). 11B
1
NMR (C6D6): 0.16 (br). 13C{1H} NMR (CD2Cl2): 37.86 (d, JC−P
=
28 Hz, P{C(CH3)3}3), 30.41 (s, P{C(CH3)3}3), 27.58 (s, P{C6H11}2),
27.53 (d, JC−P = 6 Hz, P{C6H11}2), 27.41 (d, P{C6H11}2), 26.87 (s,
P{C6H11}2). 19F NMR (C6D6): −132.42 (br m, 2F, C6F4), −134.21
3
(br m, 2F, C6F4), −134.54 (m, 4F, o-C6F5), −160.87 (t, 2F, JF−F
=
3
21 Hz, p-C6F5), −165.72 (td, 4F, JF−F = 21, 8 Hz, m-C6F5), −181.13
(br s, 1F, B-F). 31P{1H} NMR (C6D6): 48.99 (s, 1P, HPtBu3), −10.37
(t, 3JP−F = 38 Hz, 1P, PCy2). Anal. Calcd for C42H50BF15P2: C, 55.28;
H, 5.52; Found: C, 55.45; H, 5.63.
8. Yield 59 mg (81%). 1H NMR (CD2Cl2): 5.55 (d, 1JH−P = 446 Hz,
2H, H-P{C(CH3)3}3), 2.30−1.19 (br m, 44H, P{C6H11}2), 1.56
3
(d, JH−P = 16 Hz, 54H, H−P{C(CH3)3}3). 11B NMR (CD2Cl2):
−0.32 (br). 13C{1H} NMR (CD2Cl2) partial: 37.40 (d, 1JC−P = 27 Hz,
P{C(CH3)3}3), 29.96 (s, P{C(CH3)3}3), 32.75 (s, P{C6H11}2), 29.51
(s, P{C6H11}2), 28.83 (s, P{C6H11}2), 27.27 (d, JC−P = 7 Hz,
P{C6H11}2), 26.51 (s, P{C6H11}2). 19F NMR (CD2Cl2): −129.30 (br s,
4F, C6F4), −135.42 (br dm, 4F, C6F4), −136.19 (br m, 8F, o-C6F5),
1
5. white powder. Yield 660 mg (92%). H NMR (CD2Cl2): 8.19
(s, 1H, NCHN), 7.01 (s, 4H, m-MesAr-H), 4.42 (s, 4H, NCH2CH2N),
2.32 (s, 18H, Mes-CH3), 2.20−1.12 (br m, 22 H, P{C6H11}2). 11B
NMR (CD2Cl2): −0.49 (br). 13C{1H} NMR (CD2Cl2) partial: 160.36
(s, NCHN), 141.77 (s, ipso-MesAr-C-N), 135.40 (s, o-MesAr-C),
130.61 (s, m-MesAr-C), 130.30 (s, p-MesAr-C), 51.96 (s, NCH2-
CH2N), 32.44 (br m, P{C6H11}2), 29.81 (s, P{C6H11}2), 28.98
(s, P{C6H11}2), 27.75 (br m, P{C6H11}2), 27.56 (br m, P{C6H11}2),
3
3
−163.37 (t, 4F, JF−F = 20 Hz, p-C6F5), −167.76 (t, 8F, JF−F = 20,
7 Hz, meta-C6F5), −189.45 (br s, 2F, B-F). 31P{1H} NMR (CD2Cl2):
55.96 (s, 2P, PtBu3), 25.75 (s, 2P, PCy2). Anal. Calcd for
C84H100B2Cl2F30P4Pd: C, 50.38; H, 5.03; Found: C, 50.67; H, 5.37.
26.81 (s, P{C6H11}2), 21.29 (s, Mes-p-CH3), 17.91 (s, Mes-o-CH3). 19
F
1
9. Beige powder. Yield 77 mg (47%). H NMR (CD2Cl2): 7.85
NMR (CD2Cl2): −133.80 (m, 2F, C6F4), −135.81 (m, 2F, C6F4),
(s, 2H, NCHN), 6.98 (s, 8H, m-MesAr-H), 4.33 (s, 8H, NCH2CH2N),
2.77 (br m, 4H, P{C6H11}2), 2.30 (s, 12H, Mes-p-CH3), 2.26 (s, 24H,
Mes-o-CH3), 2.14−1.67 (br m, 40 H, P{C6H11}2). 11B NMR
(CD2Cl2): −0.82 (br). 13C{1H} NMR (CD2Cl2) partial: 158.91
(s, NCHN), 141.65 (s, ipso-MesAr−C-N), 135.37 (s, o-MesAr−C),
130.46 (s, m-MesAr−C), 130.07 (s, p-MesAr−C), 51.82 (s, NCH2-
CH2N), 32.96 (m, P{C6H11}2), 29.75 (d, JC−P = 3 Hz, P{C6H11}2),
28.99 (d, JC−P = 3 Hz, P{C6H11}2), 27.52 (s, P{C6H11}2), 21.14
3
−135.67 (m, 4F o-C6F5), −162.64 (t, 2F, JF−F = 21 Hz, p-C6F5),
3
−166.92 (td, 4F, JF−F = 21, 4.75 Hz, m-C6F5), −189.90 (br s, 1F,
B-F). 31P{1H} NMR (CD2Cl2): −10.69 (t, 3JP−F = 35 Hz, PCy2). Anal.
Calcd for C51H49BF15N2P: C, 60.25; H, 4.86; N, 2.76; Found: C,
60.51; H, 5.21; N, 3.18.
Synthesis of [BaseH]2[trans-Cl2Ni(Cy2PC6F4BF(C6F5)2)2] (Base =
tBu3P 6, SIMes 7). These compounds were prepared in a similar
fashion and thus only one preparation is detailed. A solution of 4
(0.075 g, 0.082 mmol) in CH2Cl2 (4 mL) was added to a solution of
NiCl2(DME) (0.0099 g, 0.045 mmol) in CH2Cl2 (4 mL). The reaction
mixture was stirred at room temperature overnight to give an opaque
pink/purple solution. The mixture was filtered through glass wool, and
the resulting clear pink/purple solution was concentrated to 1 mL via
vacuum. Twelve milliliters of pentane were added to precipitate a pink
solid, which was washed with 5 mL of pentane and dried via vacuum.
6. Pink powder. Yield 58 mg (73%). Crystals suitable for X-ray
diffraction were grown from a layered CH2Cl2/pentane solution.
(s, Mes-p-CH3), 17.66 (s, Mes-o-CH3). 19F NMR (CD2Cl2): −134.62
3
(br s, 8F, C6F4), −135.52 (br m, 8F o-C6F5), −162.35 (t, 4F, JF−F
=
3
20 Hz, p-C6F5), −167.17 (dt, 8F, JF−F = 20, 5 Hz, m-C6F5), −191.26
(br s, 2F, B-F). 31P{1H} NMR (CD2Cl2): 26.05 (s, PCy2). Anal. Calcd
for C102H98B2Cl2F30N4P2Pd: C, 55.42; H, 4.47; N, 2.53; Found: C,
55.86; H, 4.51; N, 2.63.
1
15. Pale yellow powder. Yield 77 mg (47%). H NMR (CD2Cl2):
8.00 (s, 2H, NCHN), 7.03 (s, 8H, m-MesAr-H), 4.44 (s, 8H,
NCH2CH2N), 3.01 (br s, 4H, CH2CH2O), 2.33 (s, 24H, Mes-o-CH3),
2.31 (s, 12H, Mes-p-CH3), 1.76 (br s, 8H, PCH2CH2CH2), (1.61 (br s,
4H, PCH2CH2), 1.37 (t, 36H, 3JH−P = 6 Hz, P{C(CH3)3}2). 11B NMR
(CD2Cl2): −3.02 (s). 13C{1H} NMR (CD2Cl2) partial: 160.76 (s,
1
1H NMR (CD2Cl2): 5.48 (d, JH−P = 445 Hz, 2H, H-P{C(CH3)3}3),
2.20−1.29 (br m, 44H, P{C6H11}2), 1.54 (d, 3JH−P = 16 Hz, 54H, H−
P{C(CH3)3}3). 11B NMR (CD2Cl2): δ −0.76 (br). 13C{1H} NMR
NCHN), 141.90 (s, ipso-MesAr−C-N), 135.13 (s, o-MesAr−C),
1
2
(CD2Cl2) partial: 37.55 (d, JC−P = 27 Hz, P{C(CH3)3}3), 30.34
130.60 (s, m-MesAr−C), 130.01 (s, p-MesAr−C), 63.93 (d, JC−B
=
1
(s, P{C(CH3)3}3), 29.96 (s, P{C6H11}2), 29.28 (s, P{C6H11}2), 27.88
7 Hz, CH2CH2O), 61.04 (d, JC−P = 10 Hz, PCH2CH2), 51.87
(s, NCH2CH2N), 30.85 (br m, P{C(CH3)3}2), 30.76 (br d,
P{C(CH3)3}2), 23.44 (s, CH2CH2O), 22.77 (s, PCH2CH2), 21.15
(s, Mes-p-CH3), 17.79 (s, Mes-o-CH3). 19F NMR (CD2Cl2): −133.80
3
(d, JC−P = 7 Hz, P{C6H11}2), 27.02 (s, P{C6H11}2). 19F NMR
(CD2Cl2): −128.05 (br m, 4F, C6F4), −134.65 (br s, 4F, C6F4),
−135.25 (br s, 8F o-C6F5), −162.44 (br m, 4F, p-C6F5), −166.81 (br s,
8F, m-C6F5), −188.99 (br s, 2F, B-F). 31P{1H} NMR (CD2Cl2): 56.33
(s, 2P, H-PtBu3), 10.17 (s, 2P, PCy2). Anal. Calcd for
3
3
(br d, JF−F = 22 Hz, 4F, o-C6F5), −163.90 (t, JF−F = 20 Hz, 2F,
p-C6F5), −167.29 (t, JF−F = 20 Hz, 4F, m-C6F5). 31P{1H} NMR
3
4713
dx.doi.org/10.1021/ic2026895 | Inorg. Chem. 2012, 51, 4711−4721